Agilent Technologies, Inc. $A Shares Acquired by Fenimore Asset Management Inc

Key Points

• Fenimore Asset Management Inc increased its stake in Agilent Technologies, acquiring an additional 4,823 shares, bringing their total to 180,880 shares, valued at approximately $21.3 million.
• Agilent Technologies reported a quarterly earnings per share (EPS) of $1.37, meeting analyst expectations, along with a revenue increase of 10.1% year-over-year to $1.74 billion.
• The company announced a quarterly dividend of $0.248 per share, translating to an annualized total of $0.99, with a yield of 0.7% for shareholders.

Fenimore Asset Management Inc lifted its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 180,880 shares of the medical research company's stock after purchasing an additional 4,823 shares during the quarter. Fenimore Asset Management Inc owned about 0.06% of Agilent Technologies worth $21,346,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of A. Generation Investment Management LLP raised its position in Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after purchasing an additional 824,243 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock valued at $448,748,000 after buying an additional 604,124 shares during the period. Mackenzie Financial Corp boosted its stake in shares of Agilent Technologies by 141.5% in the first quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock valued at $109,481,000 after purchasing an additional 548,344 shares during the period. Woodline Partners LP increased its position in shares of Agilent Technologies by 681.6% during the first quarter. Woodline Partners LP now owns 522,073 shares of the medical research company's stock worth $61,072,000 after acquiring an additional 455,276 shares during the period. Finally, Parnassus Investments LLC increased its holdings in Agilent Technologies by 38.3% during the 1st quarter. Parnassus Investments LLC now owns 1,577,999 shares of the medical research company's stock worth $184,594,000 after purchasing an additional 437,242 shares during the period.

Agilent Technologies Stock Performance

Shares of A opened at $141.91 on Monday. The stock has a market capitalization of $40.23 billion, a P/E ratio of 33.31, a P/E/G ratio of 4.62 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company's fifty day moving average is $122.80 and its two-hundred day moving average is $116.34.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the prior year, the business posted $1.32 EPS. The company's revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, September 30th. Agilent Technologies's payout ratio is presently 23.24%.

Wall Street Analysts Forecast Growth

A has been the subject of several recent analyst reports. Barclays lifted their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating in a research report on Thursday. Evercore ISI lowered their price target on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a report on Thursday, August 28th. Weiss Ratings reiterated a "hold (c)" rating on shares of Agilent Technologies in a research note on Saturday, September 27th. Wells Fargo & Company raised their price objective on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a report on Monday, September 15th. Finally, Robert W. Baird upped their target price on shares of Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a report on Thursday, August 28th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $142.17.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.